Related Experiment Video
Updated: May 2, 2026

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
Published on: April 18, 2011
Can Spasticity Be Prevented? Insights from Preclinical and Clinical Evidence
Radha Korupolu1, Argyrios Stampas1
1Department of Physical Medicine and Rehabilitation, McGovern Medical School, The University of Texas Health Science Center, Houston, TX, USA; TIRR Memorial Hermann Hospital, 1333 Moursund Street, Houston, TX 77030, USA.
Spasticity, a disabling condition after central nervous system injury, may be preventable. Early interventions show promise in mitigating this progressive neurological disorder.
Area of Science:
- Neurology
- Neuroscience
- Rehabilitation Medicine
Background:
- Spasticity is a common, disabling consequence of central nervous system (CNS) injury.
- It is often viewed as an unavoidable outcome of conditions like stroke and spinal cord injury.
- Emerging evidence suggests spasticity might be preventable or manageable with early interventions.
Purpose of the Study:
- To explore the pathophysiology and natural history of spasticity in various neurological conditions.
- To review strategies for the early identification of spasticity.
- To critically examine evidence supporting spasticity prevention.
Main Methods:
- Literature review of preclinical and clinical studies on spasticity.
- Analysis of data across conditions including stroke, spinal cord injury, traumatic brain injury, cerebral palsy, and multiple sclerosis.
- Evaluation of early identification and intervention strategies.
Main Results:
- Spasticity's pathophysiology and progression are complex and vary across neurological conditions.
- Early identification methods are crucial for timely intervention.
- Preclinical and clinical data indicate potential for spasticity prevention or mitigation.
Conclusions:
- Spasticity is not necessarily an unavoidable consequence of CNS injury.
- Targeted, early interventions hold significant potential for preventing or reducing spasticity.
- Further research and clinical application of preventive strategies are warranted.
More Related Videos
07:20Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
07:12Clinical Efficacy of an Innovative Multidimensional Traction Therapy in Moderate Adolescent Idiopathic Scoliosis
Published on: February 10, 2026
Related Concept Videos
Spinal Cord Injury ll: Pathophysiology
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Secondary Spinal Cord Injury llI: Pathophysiology